Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I-Lin Ho

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Nature Communications|April 17, 2023
Ether phospholipids are required for mitochondrial reactive oxygen species homeostasisZiheng Chen, I-Lin Ho, Melinda Soeung, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 2023
SMARCB1 regulates the hypoxic stress response in sickle cell traitMelinda Soeung, Luigi Perelli, Ziheng Chen, et al.
Science (New York, N.Y.)|September 16, 2021
Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesisEdoardo Del Poggetto, I-Lin Ho, Chiara Balestrieri, et al.
Nature|March 29, 2019
Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancerWantong Yao, Johnathon L Rose, Wei Wang, et al.
Science Advances|March 13, 2024
Clonal dominance defines metastatic dissemination in pancreatic cancerI-Lin Ho, Chieh-Yuan Li, Fuchenchu Wang, et al.
Cancer Research|April 6, 2026
DPY30 is an epigenetic decoupler linking replication stress to immunoediting in pancreatic cancerFrancesca Citron, Luca Cecchetto, Elisabetta Granato, et al.
Biorxiv : the Preprint Server for Biology|November 1, 2024
WRAD core perturbation impairs DNA replication fidelity promoting immunoediting in pancreatic cancerFrancesca Citron, I-Lin Ho, Chiara Balestrieri, et al.
Nature Communications|November 25, 2025
Nivolumab plus ipilimumab induce hyper-progression in renal medullary carcinoma: results of a phase II trial and preclinical evidenceMelinda Soeung, Xinmiao Yan, Ciro Zanca, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Nature Communications|April 17, 2023
Ether phospholipids are required for mitochondrial reactive oxygen species homeostasisZiheng Chen, I-Lin Ho, Melinda Soeung, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 2023
SMARCB1 regulates the hypoxic stress response in sickle cell traitMelinda Soeung, Luigi Perelli, Ziheng Chen, et al.
Science (New York, N.Y.)|September 16, 2021
Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesisEdoardo Del Poggetto, I-Lin Ho, Chiara Balestrieri, et al.
Nature|March 29, 2019
Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancerWantong Yao, Johnathon L Rose, Wei Wang, et al.
Science Advances|March 13, 2024
Clonal dominance defines metastatic dissemination in pancreatic cancerI-Lin Ho, Chieh-Yuan Li, Fuchenchu Wang, et al.
Cancer Research|April 6, 2026
DPY30 is an epigenetic decoupler linking replication stress to immunoediting in pancreatic cancerFrancesca Citron, Luca Cecchetto, Elisabetta Granato, et al.
Biorxiv : the Preprint Server for Biology|November 1, 2024
WRAD core perturbation impairs DNA replication fidelity promoting immunoediting in pancreatic cancerFrancesca Citron, I-Lin Ho, Chiara Balestrieri, et al.
Nature Communications|November 25, 2025
Nivolumab plus ipilimumab induce hyper-progression in renal medullary carcinoma: results of a phase II trial and preclinical evidenceMelinda Soeung, Xinmiao Yan, Ciro Zanca, et al.
Pageof 3